These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15718650)

  • 1. The role of implantable sensors for management of heart failure.
    Kadhiresan K; Carlson G
    Stud Health Technol Inform; 2004; 108():219-27. PubMed ID: 15718650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device.
    Adamson PB; Smith AL; Abraham WT; Kleckner KJ; Stadler RW; Shih A; Rhodes MM;
    Circulation; 2004 Oct; 110(16):2389-94. PubMed ID: 15313946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implant experience with an implantable hemodynamic monitor for the management of symptomatic heart failure.
    Steinhaus D; Reynolds DW; Gadler F; Kay GN; Hess MF; Bennett T;
    Pacing Clin Electrophysiol; 2005 Aug; 28(8):747-53. PubMed ID: 16104999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable hemodynamic monitors: success in the pursuit of failure?
    Brinker JA
    Pacing Clin Electrophysiol; 2005 Aug; 28(8):743-6. PubMed ID: 16104998
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.
    Bourge RC; Abraham WT; Adamson PB; Aaron MF; Aranda JM; Magalski A; Zile MR; Smith AL; Smart FW; O'Shaughnessy MA; Jessup ML; Sparks B; Naftel DL; Stevenson LW;
    J Am Coll Cardiol; 2008 Mar; 51(11):1073-9. PubMed ID: 18342224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.
    Small RS; Wickemeyer W; Germany R; Hoppe B; Andrulli J; Brady PA; Labeau M; Koehler J; Sarkar S; Hettrick DA; Tang WH
    J Card Fail; 2009 Aug; 15(6):475-81. PubMed ID: 19643357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating device-based monitoring into clinical practice: insights from a large heart failure clinic.
    Small RS
    Am J Cardiol; 2007 May; 99(10A):17G-22G. PubMed ID: 17512418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fundamentals of intrathoracic impedance monitoring in heart failure.
    Wang L
    Am J Cardiol; 2007 May; 99(10A):3G-10G. PubMed ID: 17512421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure.
    Fantoni C; Raffa S; Regoli F; Giraldi F; La Rovere MT; Prentice J; Pastori F; Fratini S; Salerno-Uriarte JA; Klein HU; Auricchio A
    J Am Coll Cardiol; 2005 Nov; 46(10):1875-82. PubMed ID: 16286175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How well are chronic heart failure patients being managed?
    Fonarow GC
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
    Pires LA
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in heart rate variability, quality of life, and activity in cardiac resynchronization therapy patients: results of the HF-HRV registry.
    Gilliam FR; Kaplan AJ; Black J; Chase KJ; Mullin CM
    Pacing Clin Electrophysiol; 2007 Jan; 30(1):56-64. PubMed ID: 17241316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological approach to monitor patients in congestive heart failure: application of a new implantable device-based system to monitor daily life activity and ventilation.
    Page E; Cazeau S; Ritter P; Galley D; Casset C
    Europace; 2007 Aug; 9(8):687-93. PubMed ID: 17478462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Device monitoring of intrathoracic impedance: clinical observations from a patient registry.
    Andriulli J
    Am J Cardiol; 2007 May; 99(10A):23G-8G. PubMed ID: 17512419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telemonitoring in chronic heart failure.
    Hasan A; Paul V
    Eur Heart J; 2011 Jun; 32(12):1457-64. PubMed ID: 21289040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
    Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
    Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Device trials in heart failure: a focused summary.
    Hedrich O; Weinstock J; Link M; Homoud M; Estes M
    Rev Cardiovasc Med; 2005; 6 Suppl 2():S21-31. PubMed ID: 15891701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).
    Braunschweig F; Ford I; Conraads V; Cowie MR; Jondeau G; Kautzner J; Lunati M; Munoz Aguilera R; Man Yu C; Marijianowski M; Borggrefe M; van Veldhuisen DJ;
    Eur J Heart Fail; 2008 Sep; 10(9):907-16. PubMed ID: 18715826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic monitoring strategies in heart failure management.
    Piccini JP; Hranitzky P
    Am Heart J; 2007 Apr; 153(4 Suppl):12-7. PubMed ID: 17394898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Device based treatment of heart failure.
    Patwala AY; Wright DJ
    Postgrad Med J; 2005 May; 81(955):286-91. PubMed ID: 15879039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.